MICHELLE EGLER: Open Payments
NPI 1881990174 · DEFIANCE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 50 payments from 18 companies in 2025. Trend: 2023 $544 · 2024 $795 · 2025 $965
Food & beverage: $965
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $159 |
| Novo Nordisk Inc | 12 | $140 |
| Madrigal Pharmaceuticals | 1 | $113 |
| Lilly USA, LLC | 4 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $70 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| ABBVIE INC. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
| PFIZER INC. | 2 | $38 |
Products named: FARXIGA, REZDIFFRA, JARDIANCE, Wegovy, TRELEGY ELLIPTA, VRAYLAR, REXULTI, XIFAXAN.
Industry payments across OH — which companies pay providers there.
